These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 1358044

  • 1. [Non invasive evaluation of cardiovascular effects of nebivolol in patients with cardiac insufficiency].
    Boutelant S, Lechat P, Komajda M, Isnard R, Salloum J, Gagey S, Bertholon JF, Grosgogeat Y.
    Arch Mal Coeur Vaiss; 1992 Jun; 85(6):863-70. PubMed ID: 1358044
    [Abstract] [Full Text] [Related]

  • 2. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
    Predel HG, Mainka W, Schillings W, Knigge H, Montiel J, Fallois J, Agrawal R, Schramm T, Graf C, Giannetti BM, Bjarnason-Wehrens B, Prinz U, Rost RE.
    J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
    [Abstract] [Full Text] [Related]

  • 3. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
    Wolf SC, Buck-Müller N, Görner S, Risler T, Brehm BR.
    Med Klin (Munich); 2003 Jan 15; 98(1):1-6. PubMed ID: 12540987
    [Abstract] [Full Text] [Related]

  • 4. Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X.
    Sen N, Tavil Y, Erdamar H, Yazici HU, Cakir E, Akgül EO, Bilgi C, Erbil MK, Poyraz F, Okyay K, Turfan M, Cemri M.
    Anadolu Kardiyol Derg; 2009 Oct 15; 9(5):371-9. PubMed ID: 19819787
    [Abstract] [Full Text] [Related]

  • 5. Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study.
    Conraads VM, Metra M, Kamp O, De Keulenaer GW, Pieske B, Zamorano J, Vardas PE, Böhm M, Dei Cas L.
    Eur J Heart Fail; 2012 Feb 15; 14(2):219-25. PubMed ID: 22147202
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
    Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators.
    Eur Heart J; 2005 Feb 15; 26(3):215-25. PubMed ID: 15642700
    [Abstract] [Full Text] [Related]

  • 7. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2150-8. PubMed ID: 19497441
    [Abstract] [Full Text] [Related]

  • 8. Nebivolol for heart failure in the elderly.
    Tavazzi L.
    Expert Rev Cardiovasc Ther; 2007 May 09; 5(3):423-33. PubMed ID: 17489667
    [Abstract] [Full Text] [Related]

  • 9. Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
    de Boer RA, Doehner W, van der Horst IC, Anker SD, Babalis D, Roughton M, Coats AJ, Flather MD, van Veldhuisen DJ, SENIORS Investigators.
    Am J Cardiol; 2010 Jul 01; 106(1):78-86.e1. PubMed ID: 20609652
    [Abstract] [Full Text] [Related]

  • 10. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C.
    J Am Coll Cardiol; 2009 Apr 28; 53(17):1532-8. PubMed ID: 19389564
    [Abstract] [Full Text] [Related]

  • 11. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE, Philipp T.
    Dtsch Med Wochenschr; 2006 Nov 10; 131(45):2545-50. PubMed ID: 17091442
    [Abstract] [Full Text] [Related]

  • 12. [Effects of a superselective beta1-adrenoblocker nebivolol on the course of coronary heart disease and insulin resistance in patients with diabetes mellitus type 2 after coronary artery bypass grafting].
    Tepliakov AT, Kuznetsova AV, Lukinov AV, Levshin AV.
    Ter Arkh; 2007 Nov 10; 79(12):38-43. PubMed ID: 18220029
    [Abstract] [Full Text] [Related]

  • 13. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J, Faülhaber HD.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
    [Abstract] [Full Text] [Related]

  • 14. Nebivolol: new therapy update.
    Sule SS, Frishman W.
    Cardiol Rev; 2006 Jul 27; 14(5):259-64. PubMed ID: 16924166
    [Abstract] [Full Text] [Related]

  • 15. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec 27; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of nebivolol on cardiovascular changes associated with a rat model of insulin-resistance.
    Renna N, Risler N, Cruzado M, Gonzalez S, Lama C, Miatello RM.
    Cell Mol Biol (Noisy-le-grand); 2005 Nov 08; 51(6):531-7. PubMed ID: 16309577
    [Abstract] [Full Text] [Related]

  • 18. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
    Wisenbaugh T, Katz I, Davis J, Essop R, Skoularigis J, Middlemost S, Röthlisberger C, Skudicky D, Sareli P.
    J Am Coll Cardiol; 1993 Apr 08; 21(5):1094-100. PubMed ID: 8096228
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure.
    Brune S, Schmidt T, Tebbe U, Kreuzer H.
    Angiology; 1990 Sep 08; 41(9 Pt 1):696-701. PubMed ID: 1977335
    [Abstract] [Full Text] [Related]

  • 20. Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients.
    Kaiser T, Heise T, Nosek L, Eckers U, Sawicki PT.
    J Hypertens; 2006 Jul 08; 24(7):1397-403. PubMed ID: 16794490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.